title: Comparison of five in vitro digestion models to in vivo experimental results: lead bioaccessibility in the human gastrointestinal tract.
abstract: This paper presents a multi-laboratory comparison study of in vitro models assessing bioaccessibility of soil-bound lead in the human gastrointestinal tract under simulated fasted and fed conditions. Oral bioavailability data from a previous human in vivo study on the same soil served as a reference point. In general, the bioaccessible lead fraction was significantly (P<0.05) different between the in vitro methods and ranged for the fasted models from 2% to 33% and for the fed models from 7% to 29%. The in vivo bioavailability data from literature were 26.2+/-8.1% for fasted conditions, compared to 2.5+/-1.7% for fed conditions. Under fed conditions, all models returned higher bioaccessibility values than the in vivo bioavailability; whereas three models returned a lower bioaccessibility than bioavailability under fasted conditions. These differences are often due to the method's digestion parameters that need further optimization. An important outcome of this study was the determination that the method for separating the bioaccessible lead from the non-bioaccessible fraction (centrifugation, filtration, ultrafiltration) is crucial for the interpretation of the results. Bioaccessibility values from models that use more stringent separation methods better approximate in vivo bioavailability results, yet at the expense of the level of conservancy. We conclude from this study that more optimization of in vitro digestion models is needed for use in risk assessment. Moreover, attention should be paid to the laboratory separation method since it largely influences what fraction of the contaminant is considered bioaccessible.
authors.affiliation: LabMET, Ghent University, Ghent, Belgium. tom.vandewiele@ugent.be
authors.forename: Tom R
authors.initials: TR
authors.lastname: Van de Wiele
authors.forename: Agnes G
authors.initials: AG
authors.lastname: Oomen
authors.forename: Joanna
authors.initials: J
authors.lastname: Wragg
authors.forename: Mark
authors.initials: M
authors.lastname: Cave
authors.forename: Mans
authors.initials: M
authors.lastname: Minekus
authors.forename: Alfons
authors.initials: A
authors.lastname: Hack
authors.forename: Christa
authors.initials: C
authors.lastname: Cornelis
authors.forename: Cathy J M
authors.initials: CJ
authors.lastname: Rompelberg
authors.forename: Loeckie L
authors.initials: LL
authors.lastname: De Zwart
authors.forename: Ben
authors.initials: B
authors.lastname: Klinck
authors.forename: Joop
authors.initials: J
authors.lastname: Van Wijnen
authors.forename: Willy
authors.initials: W
authors.lastname: Verstraete
authors.forename: Adriënne J A M
authors.initials: AJ
authors.lastname: Sips
mesh_terms: D001682:Biological Availability; D003627:Data Interpretation, Statistical; D041981:Gastrointestinal Tract / Q000378:metabolism*; D006801:Humans; D007854:Lead / Q000032:analysis / Q000493:pharmacokinetics*; D008954:Models, Biological; D012987:Soil / Q000032:analysis; D012989:Soil Pollutants / Q000032:analysis / Q000493:pharmacokinetics*
chemical_list: D012987:Soil; D012989:Soil Pollutants; D007854:Lead